« Back to All

Respiratory - COPD and Pulm HTN

19 pageviews


Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A2.
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582.

Rationale for inclusion: The largest series of patients undergoing fecal transplant for fulminant C. diff.

Citations  - To review the number of citations for this landmark paper, visit Google Scholar.

Chronic obstructive pulmonary disease phenotypes: the future of COPD.
Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ.
Am J Respir Crit Care Med. 2010 Sep 1;182(5):598-604.

Rationale for inclusion: Excellent description of the different phenotypes of COPD.

Citations  - To review the number of citations for this landmark paper, visit Google Scholar.

Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.
de Jong YP, Uil SM, Grotjohan HP, Postma DS, Kerstjens HA, van den Berg JW.
Chest. 2007 Dec;132(6):1741-7.

Rationale for inclusion: This study defines the role of steroids during a COPD exacerbation.

Citations  - To review the number of citations for this landmark paper, visit Google Scholar.

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Clayton LM, Jöbsis MM, Blackburn SD, Shortino D, Crow JW; Primary Pulmonary Hypertension Study Group.
N Engl J Med. 1996 Feb 1;334(5):296-301.

Rationale for inclusion: This study introduces Prostacyclin for pulm HTN treatment.

Citations  - To review the number of citations for this landmark paper, visit Google Scholar.

Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, Simonneau G, Benito S, Gasparetto A, Lemaire F, et al.
N Engl J Med. 1995 Sep 28;333(13):817-22.

Rationale for inclusion: Well referenced NEJM article on non-invasive ventilation for COPD.

Citations  - To review the number of citations for this landmark paper, visit Google Scholar.

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA.
Ann Intern Med. 1987 Feb;106(2):196-204.

Rationale for inclusion: Highly referenced study describing Abx during COPD exacerbations.

Citations  - To review the number of citations for this landmark paper, visit Google Scholar.

« Back to All

Eastern Association for the Surgery of Trauma

Contact
633 N. Saint Clair Street, Suite 2400 Chicago, IL 60611-3295 (312) 202-5508 phone (312) 202-5064 fax managementoffice@east.org
Stay connected to EAST
Support EAST
  • AmazonSmiel
Donate Now